Ambu A/S (OTCMKTS:AMBBY) Shares Down 5%
Ambu A/S (OTCMKTS:AMBBY) Shares Down 5%
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.Ambu A/S (OTCMKTS:AMBBY – Get Rating)'s stock price was down 5% during trading on Monday . The stock traded as low as $9.63 and last traded at $9.63. Approximately 500 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 10,669 shares. The stock had previously closed at $10.14.
Ambu A/S(OTCMKTS：AMBBY-GET Rating)的股价在周一的交易中下跌了5%。该股最低交易价格为9.63美元，最新报9.63美元。午盘交易中，约有500股股票易手，较10,669股的日均成交量下降了95%。该股此前收盘报10.14美元。
Analysts Set New Price Targets
分析师设定新的价格目标
Separately, Danske lowered shares of Ambu A/S from a "buy" rating to a "hold" rating in a research note on Monday, May 9th.
另外，丹斯克在5月9日星期一的一份研究报告中将Ambu A/S的股票评级从“买入”下调至“持有”。
Ambu A/S Stock Down 5.0 %
Ambu A/S股票下跌5.0%
The firm's 50 day simple moving average is $10.18 and its 200 day simple moving average is $12.94.
该公司的50日简单移动均线切入位为10.18美元，200日简单移动均线切入位为12.94美元。
About Ambu A/S
关于Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S开发、生产医疗设备，并向世界各地的医院、诊所和救援服务销售。它在可视化、麻醉以及患者监测和诊断领域提供医疗解决方案。该公司提供内窥镜产品，如支气管镜和监护仪；以及神经学产品，包括EEG和EMG电极、EMG引导注射和术中监测产品。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Ambu A/S (AMBBY)
- What Does an Inverted Yield Curve Mean For You?
- SPY vs. QQQ: Which ETF Wins in 2022?
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- 免费获取StockNews.com关于Ambu A/S的研究报告(AMBBY)
- 收益率曲线倒置对你意味着什么？
- 标普500ETF VS QQQ：2022年哪只ETF胜出？
- 随着管理层重组，股市能否迅速反弹？
- MarketBeat：回顾中的一周8/29-9/2
- 霍梅尔在这些水平上看起来很便宜
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
接受Ambu A/S日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Ambu A/S和相关公司的最新新闻和分析师评级的每日简要摘要。
